MiMedx Group announced it has secured a revolving line of credit with Bank of America. The revolving line of credit facility, which is secured by the company’s accounts receivable and inventory, allows MiMedx to borrow up to $3 million through May 1, 2014. The facility will be used for general corporate purposes.

Kennesaw, GA-based MiMedx is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.